[go: up one dir, main page]

SE9303740L - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SE9303740L
SE9303740L SE9303740A SE9303740A SE9303740L SE 9303740 L SE9303740 L SE 9303740L SE 9303740 A SE9303740 A SE 9303740A SE 9303740 A SE9303740 A SE 9303740A SE 9303740 L SE9303740 L SE 9303740L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
abnormalities
mammal
calcium
salt
Prior art date
Application number
SE9303740A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE9303740D0 (en
Inventor
Shabtay Dikstein
Leena Lauren
Pertti Rantala
Kirsi Katila
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to SE9303740A priority Critical patent/SE9303740L/en
Publication of SE9303740D0 publication Critical patent/SE9303740D0/en
Priority to PCT/FI1994/000504 priority patent/WO1995013078A1/en
Priority to AU81083/94A priority patent/AU8108394A/en
Publication of SE9303740L publication Critical patent/SE9303740L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention concerns the use of clodronic acid or a salt thereof for making a pharmaceutical composition for the rectal treatment of abnormalities in the calcium and phosphate metabolism in a mammal.
SE9303740A 1993-11-12 1993-11-12 Pharmaceutical composition SE9303740L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition
PCT/FI1994/000504 WO1995013078A1 (en) 1993-11-12 1994-11-09 Pharmaceutical composition and use thereof
AU81083/94A AU8108394A (en) 1993-11-12 1994-11-09 Pharmaceutical composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
SE9303740D0 SE9303740D0 (en) 1993-11-12
SE9303740L true SE9303740L (en) 1995-05-13

Family

ID=20391728

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition

Country Status (3)

Country Link
AU (1) AU8108394A (en)
SE (1) SE9303740L (en)
WO (1) WO1995013078A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9776A (en) * 1967-12-11 1976-03-17 M Francis Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use
NL175882C (en) * 1977-03-28 Procter & Gamble PHARMACEUTICAL PREPARATION CONTAINING AN ANTI-INFLAMMATORY COMPOUND.

Also Published As

Publication number Publication date
SE9303740D0 (en) 1993-11-12
AU8108394A (en) 1995-05-29
WO1995013078A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
DK0891776T3 (en) Granular composition comprising simethicone and granular anhydrous calcium phosphate
EP0520690A3 (en) Calcium phosphate type hardening material for repairing living hard tissue
FI962557L (en) Use of PLA2 inhibitors in the treatment of Alzheimer's disease
FI945599A7 (en) Phosphonocarboxylate compounds for the treatment of abnormal calcium and phosphate metabolism
ZA943744B (en) Therapeutic substituted guanidines
ZA941525B (en) Use of riluzole in the treatment of nero-AIDS
FI945595A0 (en) Thiosubstituted nitrogen-containing heterocyclic phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
ITMI931649A1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
UA26973A1 (en) Agent for prophylaxis of the vascular diseases coused by the action of glycoproteinconnected peroxides
MXPA94009086A (en) Therapeutic substituted guanidines.
EP0449405A3 (en) Use of bisphosphonic acids for the treatment of calcium metabolism disorders
FI945593A7 (en) Sulfur-containing phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
TR200000455T2 (en) The use of fanquinone in the treatment of Alzheimer's disease.
FI98069C (en) Fungicidal and anti-corrosion calcium pyroborate pigments
ES2078904T3 (en) NEW DERIVATIVES OF NEPLANOCINA.
FI945596A7 (en) Quaternary nitrogen-containing phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism, as well as dental calculus and dental plaque
BR9811643A (en) Chemical bone supplementation
SE9303740L (en) Pharmaceutical composition
AP9200355A0 (en) "Therapeutic agent"
IL111137A0 (en) Process for the electrochemical dissolution of sulfur-containing and/or concentrated minerals
FI945592A7 (en) Phosphonosulfonate compounds for the treatment of abnormal calcium and phosphate metabolism
MX9201825A (en) PHARMACEUTICAL COMPOSITION CONTAINING CALCITONIN.
FI945597L (en) Quaternary nitrogen-containing phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
FI945594L (en) Thiosubstituted cyclic phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
DE19680816D2 (en) Plant for the production of insoles in shoes

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9303740-6

Format of ref document f/p: F